• 中国中文核心期刊
  • 中国科学引文数据库核心期刊
  • 中国科技核心期刊
  • 中国高校百佳科技期刊
高级检索

丙戊酸钠抗抑郁作用涉及改善海马NET和5-HTT表达

费慧芝, 胡小娅, 邱红梅, 刘丹, 周岐新

费慧芝, 胡小娅, 邱红梅, 刘丹, 周岐新. 丙戊酸钠抗抑郁作用涉及改善海马NET和5-HTT表达[J]. 中国药科大学学报, 2016, 47(4): 474-478. DOI: 10.11665/j.issn.1000-5048.20160414
引用本文: 费慧芝, 胡小娅, 邱红梅, 刘丹, 周岐新. 丙戊酸钠抗抑郁作用涉及改善海马NET和5-HTT表达[J]. 中国药科大学学报, 2016, 47(4): 474-478. DOI: 10.11665/j.issn.1000-5048.20160414
FEI Huizhi, HU Xiaoya, QIU Hongmei, LIU Dan, ZHOU Qixin. Improvement of NET and 5-HTT expression involved in the anti-depressive effect of valproate[J]. Journal of China Pharmaceutical University, 2016, 47(4): 474-478. DOI: 10.11665/j.issn.1000-5048.20160414
Citation: FEI Huizhi, HU Xiaoya, QIU Hongmei, LIU Dan, ZHOU Qixin. Improvement of NET and 5-HTT expression involved in the anti-depressive effect of valproate[J]. Journal of China Pharmaceutical University, 2016, 47(4): 474-478. DOI: 10.11665/j.issn.1000-5048.20160414

丙戊酸钠抗抑郁作用涉及改善海马NET和5-HTT表达

基金项目: 国家自然科学基金资助项目(No.31400881)

Improvement of NET and 5-HTT expression involved in the anti-depressive effect of valproate

  • 摘要: 采用孤养结合慢性不可预见性温和刺激(CUMS)方式建立抑郁模型,探讨丙戊酸钠抗抑郁作用与改善海马去甲肾上腺素转运体(norepinephrine transporter,NET)、5-羟色胺转运体(serotonin transporter,5-HTT)表达之间的关系。60只雄性SD大鼠随机分为对照组(NG)、模型组(MG)、丙戊酸钠对照组(VNG)及丙戊酸钠模型组(VMG)。通过开场实验、强迫游泳试验评价大鼠抑郁行为。通过生物化学法测定血清丙二醛(MDA)含量及超氧化物酶(SOD)、过氧化氢酶(CAT)活性;以实时定量RT-PCR法及Western blot分析丙戊酸钠对大鼠海马NET、5-HTT mRNA及蛋白表达的影响。实验结果表明:CUMS致模型组大鼠活动减少,不动时间明显增加,MDA含量升高,SOD、CAT活性下降,海马NET mRNA及蛋白表达显著升高,5-HTT mRNA及蛋白表达明显降低,而丙戊酸钠干预可明显阻遏以上变化,但对对照组大鼠无显著影响。以上结果提示,丙戊酸钠抗抑郁作用可能涉及改善CUMS大鼠海马NET及5-HTT mRNA及蛋白的表达。
    Abstract: This study aimed at investigating the correlations between antidepressive effect of valproate and improvements of NET and 5-HTT expression in depressive rats leaded by chronic mild unpredicted stress(CUMS)with solitary condition. Sixty male SD rats were divided into normal group(NG), model group(MG), valproate treated-normal group(VNG), and valproate treated-model group(VMG), randomly. The changes of depressive behaviors were evaluated by the open-field test and force swimming test. The contents of MDA, activities of SOD and CAT in serum, the mRNA and protein expression of NET, 5-HTT in hippocampus were determined by biochemical methods, Real-time PCR and Western Blot, respectively. Results showed that CUMS can significantly decrease the activities in open-field test, SOD and CAT activities in serum, expression of 5-HTT in hippocampus, and obviously increase the immobility time in force swimming test, the level of MDA and expression of NET. The treatment of valproate obviously improved the changes induced by CUMS. However, the treatment of valproate had no significant influences on behaviors of NG rats. So, it revealed that improvements of the mRNA and protein expression of NET, 5-HTT may be involved in the antidepressive effect of valproate.
  • [1] World Health Organization.Fact sheets N° 369:depression[EB/OL].(2015-10-01)[2016-01-04] .http://www.who.int/mediacentre/factsheets/fs369/en/.html.
    [2] Dedovic K,Duchesne A,Engert V,et al.Psychological,endocrine and neural responses to social evaluation in subclinical depression[J]. Soc Cogn Affect Neurosci,2014,9(10): 1632-1644.
    [3] Quesseveur G,Gardier AM,Guiard BP.The monoaminergic tripartite synapse: a putative target for currently available antidepressant drugs[J].Curr Drug Targets,2013,14(11):1277-1294.
    [4] Fornaro M,McCarthy MJ,DeBerardis D,et al.Adjunctive agomelatine therapy in the treatment of acute bipolar II depression:a preliminary open label study[J].Neuropsych Dis Treat,2013,9:243-251.
    [5] Xie JP,Ren ZB,Ma YC,et al.Comparing study on therapeutic of outpatients with agitated or anxiety depression by combination of SSRI and sodium valproate RX [J].Chin J Clin Pharm Ther(中国临床药理学与治疗学),2013,18(1):86-89.
    [6] Unterecker S,Reif A,Hempel S,et al.Interaction of valproic acid and the antidepressant drugs doxepin and venlafaxine:analysis of therapeutic drug monitoring data under naturalistic conditions[J].Int Clin Psychopharma,2014,29(4):206-211.
    [7] Maes M,Kubera M,Obuchowiczwa E,et al.Depression′s multiple comorbidities explained by(neuro)inflammatory and oxidative & nitrosative stress pathways[J].Neuro Endocrinol Lett,2011,32(1):7-24.
    [8] Hu XY,Li N,Fei HZ,et al.Anti-depressive effect of reboxetine on non-transporter inhibition in rats[J].Acta Acad Med Mil Tert(第三军医大学学报),2012,34(19):1977-1980.
    [9] Fei HZ,Wang H,Hu XY,et al. Improvement of oxidative stress and HPA axis function and elevation of BDNF expression involved in anti-depressive effect of paroxetine in rat model[J].Chin J Clin Pharm Ther(中国临床药理学与治疗学),2012,17(10):1137-1142.
    [10] Tang M,Lei JY,Sun X,et al.Stress-induced anhedonia correlates with lower hippocampal serotonin transporter protein expression[J].Brain Res,2013,1513:127-134.
    [11] Chen P, Fan Y, Li Y, et al. Chronic social defeat up-regulates expression of norepinephrine transporter in rat brains[J].Neurochem Int,2012,60(1):9-20.
    [12] Li N,Wang H,Wen W,et al.Improvement of oxidative/anti-oxidative stress balance and expression of NET and 5-HTT involve in the anti-depressive effect of reboxetine[J].Clin Pharmocal Bull(中国药理学通报),2011,27(9):593-597.
    [13] Hu XY, Fei HZ, Jiang XH, et al. Improving oxidative stress response and reversing abnormal expression of hippocampus NET and 5-HTT involved in anti-depressive effect of venlafaxine[J].Clin Pharmocal Bull(中国药理学通报),2014,30(6):848-852.
    [14] Wang LJ,Qiu HM,Jiang XH,et al.Down-regulation of monoamine neurotransmitter synthetase expression involved in CUS-induced depression of rats[J].Chin Pharmacol Bull(中国药理学通报),2015,31(4):527-531.
    [15] Qin LJ,Liu D,Jiang XH,et al.Down-regulation of hyppocampal TH and TPH expression involved in CUMS induced depressive behaviors of rats and interfering effects of venlafaxine[J].Chin J Clin Pharm Ther(中国临床药理学与治疗学),2014,19(4):398-403.
计量
  • 文章访问数:  808
  • HTML全文浏览量:  0
  • PDF下载量:  1684
  • 被引次数: 0
出版历程
  • 刊出日期:  2016-08-24

目录

    /

    返回文章
    返回
    x 关闭 永久关闭